Cargando…
Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins
BACKGROUND: African-Americans have higher HDL, less visceral adipose tissue (VAT) and lower triglyceride (TG) and apoCIII concentrations than whites, despite being more insulin-resistant. We studied in African-American and white women the influences of insulin resistance and VAT on the apoAI concent...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280695/ https://www.ncbi.nlm.nih.gov/pubmed/25553059 http://dx.doi.org/10.1186/1743-7075-11-56 |
_version_ | 1782350880254722048 |
---|---|
author | Wang, Liyun Sacks, Frank M Furtado, Jeremy D Ricks, Madia Courville, Amber B Sumner, Anne E |
author_facet | Wang, Liyun Sacks, Frank M Furtado, Jeremy D Ricks, Madia Courville, Amber B Sumner, Anne E |
author_sort | Wang, Liyun |
collection | PubMed |
description | BACKGROUND: African-Americans have higher HDL, less visceral adipose tissue (VAT) and lower triglyceride (TG) and apoCIII concentrations than whites, despite being more insulin-resistant. We studied in African-American and white women the influences of insulin resistance and VAT on the apoAI concentrations of two HDL subspecies, one that contains apoCIII that is associated with increased risk of coronary heart disease (CHD) and one that does not have apoCIII that is associated with decreased CHD; and on the apoCIII concentrations of HDL and of the apoB lipoproteins. METHODS: The participants were 32 women (14 African-Americans, 18 white) of similar age (39 ± 12 vs. 42 ± 11y). Mean BMI was 34 kg/m(2) in the African-Americans compared to 30 in the whites. A standard diet (33% fat, 52% carbohydrate, 15% protein) was provided for 7 days followed by a test meal (40% fat, 40% carbohydrate, 20% protein) on Day 8. Insulin sensitivity index (S(I)) was calculated from the minimal model. RESULTS: After controlling for S(I), African-Americans have a higher mean apoAI level in HDL with apoCIII compared with whites (12.9 ± 2.8 and 10.9 ± 2.9 mg/dL, respectively, P = 0.05). S(I) was associated with higher apoAI in HDL with apoCIII, whereas VAT was not associated with this HDL subspecies. This pattern of results was reversed for apoCIII concentrations in apoB lipoproteins. After adjusting for S(I), African-Americans had lower apoCIII in apoB lipoproteins. S(I) was associated with lower apoCIII in total apoB lipoproteins, whereas VAT was associated with higher apoCIII in all the apoB lipoproteins. Additional adjustment for VAT tended to reduce the difference in apoCIII between the groups. CONCLUSIONS: African-American women have a higher HDL with apoCIII level than whites when controlled for insulin sensitivity. African-Americans have lower insulin sensitivity. Insulin sensitivity is associated with higher levels of HDL with apoCIII. ApoCIII levels in VLDL are lower in African-American women than whites, also affected by insulin sensitivity which is associated with low apoCIII in VLDL. VAT has a strong association with apoCIII in apoB lipoproteins but not with apoAI in HDL with apoCIII. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00484861 |
format | Online Article Text |
id | pubmed-4280695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42806952015-01-01 Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins Wang, Liyun Sacks, Frank M Furtado, Jeremy D Ricks, Madia Courville, Amber B Sumner, Anne E Nutr Metab (Lond) Research BACKGROUND: African-Americans have higher HDL, less visceral adipose tissue (VAT) and lower triglyceride (TG) and apoCIII concentrations than whites, despite being more insulin-resistant. We studied in African-American and white women the influences of insulin resistance and VAT on the apoAI concentrations of two HDL subspecies, one that contains apoCIII that is associated with increased risk of coronary heart disease (CHD) and one that does not have apoCIII that is associated with decreased CHD; and on the apoCIII concentrations of HDL and of the apoB lipoproteins. METHODS: The participants were 32 women (14 African-Americans, 18 white) of similar age (39 ± 12 vs. 42 ± 11y). Mean BMI was 34 kg/m(2) in the African-Americans compared to 30 in the whites. A standard diet (33% fat, 52% carbohydrate, 15% protein) was provided for 7 days followed by a test meal (40% fat, 40% carbohydrate, 20% protein) on Day 8. Insulin sensitivity index (S(I)) was calculated from the minimal model. RESULTS: After controlling for S(I), African-Americans have a higher mean apoAI level in HDL with apoCIII compared with whites (12.9 ± 2.8 and 10.9 ± 2.9 mg/dL, respectively, P = 0.05). S(I) was associated with higher apoAI in HDL with apoCIII, whereas VAT was not associated with this HDL subspecies. This pattern of results was reversed for apoCIII concentrations in apoB lipoproteins. After adjusting for S(I), African-Americans had lower apoCIII in apoB lipoproteins. S(I) was associated with lower apoCIII in total apoB lipoproteins, whereas VAT was associated with higher apoCIII in all the apoB lipoproteins. Additional adjustment for VAT tended to reduce the difference in apoCIII between the groups. CONCLUSIONS: African-American women have a higher HDL with apoCIII level than whites when controlled for insulin sensitivity. African-Americans have lower insulin sensitivity. Insulin sensitivity is associated with higher levels of HDL with apoCIII. ApoCIII levels in VLDL are lower in African-American women than whites, also affected by insulin sensitivity which is associated with low apoCIII in VLDL. VAT has a strong association with apoCIII in apoB lipoproteins but not with apoAI in HDL with apoCIII. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00484861 BioMed Central 2014-12-17 /pmc/articles/PMC4280695/ /pubmed/25553059 http://dx.doi.org/10.1186/1743-7075-11-56 Text en © Wang et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wang, Liyun Sacks, Frank M Furtado, Jeremy D Ricks, Madia Courville, Amber B Sumner, Anne E Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins |
title | Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins |
title_full | Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins |
title_fullStr | Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins |
title_full_unstemmed | Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins |
title_short | Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins |
title_sort | racial differences between african-american and white women in insulin resistance and visceral adiposity are associated with differences in apociii containing apoai and apob lipoproteins |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280695/ https://www.ncbi.nlm.nih.gov/pubmed/25553059 http://dx.doi.org/10.1186/1743-7075-11-56 |
work_keys_str_mv | AT wangliyun racialdifferencesbetweenafricanamericanandwhitewomenininsulinresistanceandvisceraladiposityareassociatedwithdifferencesinapociiicontainingapoaiandapoblipoproteins AT sacksfrankm racialdifferencesbetweenafricanamericanandwhitewomenininsulinresistanceandvisceraladiposityareassociatedwithdifferencesinapociiicontainingapoaiandapoblipoproteins AT furtadojeremyd racialdifferencesbetweenafricanamericanandwhitewomenininsulinresistanceandvisceraladiposityareassociatedwithdifferencesinapociiicontainingapoaiandapoblipoproteins AT ricksmadia racialdifferencesbetweenafricanamericanandwhitewomenininsulinresistanceandvisceraladiposityareassociatedwithdifferencesinapociiicontainingapoaiandapoblipoproteins AT courvilleamberb racialdifferencesbetweenafricanamericanandwhitewomenininsulinresistanceandvisceraladiposityareassociatedwithdifferencesinapociiicontainingapoaiandapoblipoproteins AT sumnerannee racialdifferencesbetweenafricanamericanandwhitewomenininsulinresistanceandvisceraladiposityareassociatedwithdifferencesinapociiicontainingapoaiandapoblipoproteins |